[1] |
Abrams P, Cardozo L, Fall M,et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society[J]. Urology, 2003, 61(1):37-49.
|
[2] |
Lee YJ, Jeong SJ, Byun SS, et al. Prevalence and correlates of nocturia in community-dwelling older men: results from the korean longitudinal study on health and aging[J]. J Urol, 2012, 53(4):263-267.
|
[3] |
文璐,王志敏,文建国,等.中老年人夜尿增多流行病学调查[J].中华老年医学杂志,2013,32(10):1120-1122.
|
[4] |
Tikkinen KA, Johnson TM, Tammela TL, et al. Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland[J]. Eur Urol, 2010, 57(3):488-496.
|
[5] |
Vaughan CP, Brown CJ, Goode PS, et al. The association of nocturia with incident falls in an elderly community-dwelling cohort[J]. Int J Clin Pract, 2010, 64(5):577-583.
|
[6] |
Lightner DJ, Krambeck AE, Jacobson DJ, et al. Nocturia is associated with an increased risk of coronary heart disease and death[J]. BJU Int, 2012, 110(6):848-853.
|
[7] |
王志敏,文建国,李金升,等.中老年人膀胱过度活动症患病率调查及危险因素分析[J].中华泌尿外科杂志,2012,33(11):831-835.
|
[8] |
Weiss JP, van Kerrebroeck PE, Klein BM, et al. Excessive nocturnal urine production is a major contributing factor to the etiology of nocturia[J]. J Urol, 2011, 186(4):1358-1363.
|
[9] |
Weiss JP, Blaivas JG. Nocturnal polyuria versus overactive bladder in nocturia[J]. Urology, 2002, 60(5):28-32.
|
[10] |
肖靖,田慧.去氨加压素与老年人夜尿增多[J].中华老年医学杂志,2012,31(4):342-344.
|
[11] |
Bliwise DL, Foley DJ, Vitiello MV, et al. Nocturia and disturbed sleep in the elderly[J]. Sleep Med, 2009, 10(5):540-548.
|
[12] |
石海林,莫曾南.夜尿对老年人生活质量和身心健康的影响[J].中华泌尿外科杂志,2008,29(7):499-501.
|
[13] |
卜晓佳,梁涛.居家与养老院65~80岁老人夜尿相关生活质量调查分析[J].中国老年保健医学,2013,11(2):11-13.
|
[14] |
Kupelian V, Wei JT, O’Leary MP, et al. Nocturia and quality of life: results from the Boston area community health survey[J]. Eur Urol, 2012, 61(1):78-84.
|
[15] |
Obayashi K, Saeki K, Negoro H, et al. Nocturia increases the incidence of depressive symptoms: a longitudinal study of the HEIJO‐KYO cohort[J]. BJU Int, 2017, 120(2):280-285.
|
[16] |
Galizia G, Langellotto A, Cacciatore F, et al. Association between nocturia and falls-related long-term mortality risk in the elderly[J]. J Am Med Dir Assoc, 2012, 13(7):640-644.
|
[17] |
Parthasarathy S, Fitzgerald M, Goodwin JL, et al. Nocturia, sleep-disordered breathing, and cardiovascular morbidity in a community-based cohort[J]. PLos One, 2012, 7(2):e30969.
|
[18] |
Bursztyn M, Jacob J, Stessman J. Usefulness of nocturia as a mortality risk factor for coronary heart disease among persons born in 1920 or 1921[J]. Am J Cardiol, 2006, 98(10):1311-1315.
|
[19] |
Liu HY, Chung MS, Wang HJ, et al. Nocturia indicates a poor health status and increases mortality in male patients with type 2 diabetes mellitus[J]. Int Urol Nephrol, 2016, 48(8):1209-1214.
|
[20] |
Furukawa S, Sakai T, Niiya T, et al. Nocturia and prevalence of erectile dysfunction in Japanese patients with type 2 diabetes mellitus: The Dogo Study[J]. J Diabetes Investig, 2016, 7(5):786-790.
|
[21] |
Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function[J]. Lancet, 1999, 354(9188):1435-1439.
|
[22] |
中华医学会老年医学分会.老年人良性前列腺增生症/下尿路症状药物治疗共识(2015)[J].中华老年医学杂志,2015,34(12):1380-1387.
|
[23] |
Gratzke C, Bachmann A, Descazeaud A, et al. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction[J]. Eur Urol, 2015, 67(6):1099-1109.
|
[24] |
Bursztyn M, Jacob J, Stessman J. Usefulness of nocturia as a mortality risk factor for coronary heart disease among persons born in 1920 or 1921[J]. Am J Cardiol, 2006, 98(10):1311-1315.
|
[25] |
Burger M, Betz D, Hampel C, et al. Efficacy and tolerability of solifenacin in men with overactive bladder: results of an observational study[J]. World J Urol, 2014, 32(4):1041-1047.
|
[26] |
Kwon T, Oh TH, Choi S, et al. Influence of daytime or nighttime dosing with solifenacin for overactive bladder with nocturia: impact on nocturia and sleep quality[J]. J Korean Med Sci, 2017, 32(9):1491-1495.
|
[27] |
Tellenbach M, Schneider M, Mordasini L, et al. Transcutaneous electrical nerve stimulation: an effective treatment for refractory non-neurogenic overactive bladder syndrome[J]? World J Urol, 2013, 31(5):1205-1210.
|
[28] |
Rezakhaniha B, Arianpour N, Siroosbakhat S. Efficacy of desmopressin in treatment of nocturia in elderly men[J]. J Res Med Sci, 2011, 16(4):516-523.
|
[29] |
van Kerrebroeck P, Rezapour M, Cortesse A, et al. Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study[J]. Eur Urol, 2007, 52(1):221-229.
|
[30] |
Weiss JP. Nocturia: focus on etiology and consequences[J]. Rev Urol, 2012, 14(3-4):48-55.
|
[31] |
Miyazaki T, Kojima S, Yamamuro M, et al. Nocturia in patients with sleep-disordered breathing and cardiovascular disease[J]. Circ J, 2015, 79(12):2632-2640.
|
[32] |
Soda T, Masui K, Okuno H, et al. Efficacy of nondrug lifestyle measures for the treatment of nocturia[J]. J Urol, 2010, 184(3):1000-1004.
|
[33] |
Vaughan CP, Endeshaw Y, Nagamia Z, et al. A multicomponent behavioural and drug intervention for nocturia in elderly men: rationale and pilot results[J]. BJU Int, 2009, 104(1):69-74.
|
[34] |
Hashim H, Abrams P. How should patients with an overactive bladder manipulate their fluid intake[J]? BJU Int, 2008, 102(1):62-66.
|